CEL SCI Corp (CVM) stock
CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
$1.19−0.12 (-9.16%)
Close on Nov 12, 2026Market cap $20.93MP/E –Yield –
Cel Sci profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2014 it was -10359.6%, against -5746.8% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2014 | Sep 30, 2014 | -10359.6% | −4612.7 |
| FY2013 | Sep 30, 2013 | -5746.8% | +332.0 |
| FY2012 | Sep 30, 2012 | -6078.8% | −3389.7 |
| FY2011 | Sep 30, 2011 | -2689.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -25671.8% | – |
See a number that looks wrong?